Obsessive-compulsive disorder: Identification, neurobiology, and treatment

Jackie L. Neel, Vivian Stevens, Joan E. Stewart

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Obsessive-compulsive disorder (OCD) is a common psychiatric disorder. It may go unrecognized, however, as many patients are embarrassed by their symptoms and are thus reluctant to report them. Recent research findings on OCD point to neurologic dysfunction in the circuitry of the orbitofrontal cortex and basal ganglia. The advent of the use of serotonin reuptake inhibitors (SRIs) as well as behavioral therapy has greatly improved treatment outcomes for patients with OCD. Given the likelihood that these patients are encountered in primary care consultations, physicians have the opportunity to play a crucial role in the early identification and proper treatment of OCD.

Original languageEnglish
Pages (from-to)81-86
Number of pages6
JournalJournal of the American Osteopathic Association
Volume102
Issue number2
StatePublished - 4 Mar 2002

Fingerprint

Neurobiology
Obsessive-Compulsive Disorder
Serotonin Uptake Inhibitors
Primary Care Physicians
Therapeutics
Neurologic Manifestations
Basal Ganglia
Prefrontal Cortex
Psychiatry
Referral and Consultation
Research

Keywords

  • Basal ganglia
  • Behavioral therapy
  • DSM-IV
  • Diagnostic and Statistical Manual of Mental Disorders
  • Obsessive-compulsive disorder
  • Orbitofrontal cortex
  • PANDAS
  • Serotonin reuptake inhibitor

Cite this

@article{6904698530fb478fb57c999b8876fdec,
title = "Obsessive-compulsive disorder: Identification, neurobiology, and treatment",
abstract = "Obsessive-compulsive disorder (OCD) is a common psychiatric disorder. It may go unrecognized, however, as many patients are embarrassed by their symptoms and are thus reluctant to report them. Recent research findings on OCD point to neurologic dysfunction in the circuitry of the orbitofrontal cortex and basal ganglia. The advent of the use of serotonin reuptake inhibitors (SRIs) as well as behavioral therapy has greatly improved treatment outcomes for patients with OCD. Given the likelihood that these patients are encountered in primary care consultations, physicians have the opportunity to play a crucial role in the early identification and proper treatment of OCD.",
keywords = "Basal ganglia, Behavioral therapy, DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Obsessive-compulsive disorder, Orbitofrontal cortex, PANDAS, Serotonin reuptake inhibitor",
author = "Neel, {Jackie L.} and Vivian Stevens and Stewart, {Joan E.}",
year = "2002",
month = "3",
day = "4",
language = "English",
volume = "102",
pages = "81--86",
journal = "Journal of the American Osteopathic Association",
issn = "0098-6151",
publisher = "American Osteopathic Association",
number = "2",

}

Obsessive-compulsive disorder : Identification, neurobiology, and treatment. / Neel, Jackie L.; Stevens, Vivian; Stewart, Joan E.

In: Journal of the American Osteopathic Association, Vol. 102, No. 2, 04.03.2002, p. 81-86.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Obsessive-compulsive disorder

T2 - Identification, neurobiology, and treatment

AU - Neel, Jackie L.

AU - Stevens, Vivian

AU - Stewart, Joan E.

PY - 2002/3/4

Y1 - 2002/3/4

N2 - Obsessive-compulsive disorder (OCD) is a common psychiatric disorder. It may go unrecognized, however, as many patients are embarrassed by their symptoms and are thus reluctant to report them. Recent research findings on OCD point to neurologic dysfunction in the circuitry of the orbitofrontal cortex and basal ganglia. The advent of the use of serotonin reuptake inhibitors (SRIs) as well as behavioral therapy has greatly improved treatment outcomes for patients with OCD. Given the likelihood that these patients are encountered in primary care consultations, physicians have the opportunity to play a crucial role in the early identification and proper treatment of OCD.

AB - Obsessive-compulsive disorder (OCD) is a common psychiatric disorder. It may go unrecognized, however, as many patients are embarrassed by their symptoms and are thus reluctant to report them. Recent research findings on OCD point to neurologic dysfunction in the circuitry of the orbitofrontal cortex and basal ganglia. The advent of the use of serotonin reuptake inhibitors (SRIs) as well as behavioral therapy has greatly improved treatment outcomes for patients with OCD. Given the likelihood that these patients are encountered in primary care consultations, physicians have the opportunity to play a crucial role in the early identification and proper treatment of OCD.

KW - Basal ganglia

KW - Behavioral therapy

KW - DSM-IV

KW - Diagnostic and Statistical Manual of Mental Disorders

KW - Obsessive-compulsive disorder

KW - Orbitofrontal cortex

KW - PANDAS

KW - Serotonin reuptake inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0036170974&partnerID=8YFLogxK

M3 - Article

C2 - 11866396

AN - SCOPUS:0036170974

VL - 102

SP - 81

EP - 86

JO - Journal of the American Osteopathic Association

JF - Journal of the American Osteopathic Association

SN - 0098-6151

IS - 2

ER -